Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natural weak acid repair cream for infantile atopic dermatitis and microecology
ChiCTR2500101011Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mometasone in atopic dermatitis (AD) (7 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Overall improvement rate. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
mometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2500101011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101011.